Albany, NY -- (SBWIRE) -- 10/05/2018 -- The emphasis on personalized medicine is expected to rise in response to the increasing incidence of chronic ailments such as cancer. Furthermore, the rising preference towards non-invasive procedures as a treatment option for cancer will in turn fuel the demand for liquid biopsy market, finds a report, titled "Liquid Biopsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 – 2026." The report recently added to ResearchMoz.us offers a holistic overview of the global liquid biopsy market, covering market intelligence for the companies operating therein and in-depth insights into the prevailing trend. It is therefore compiled to offer a 360 degree overview of the market to its stakeholders. Furthermore, the report contains profiles of some of the leading companies operating in the liquid biopsy market and gauges the impact of the strategies they adopt on the overall market.
The report predicts significant increase in the clinical applications of liquid biopsy in the coming years. The rising demand for effective treatment monitoring for cancer, therapy selection, and non-invasive prenatal testing has created an environment conducive to the growth of the liquid biopsy market. Transplant diagnostics, heterogeneity, recurrence monitoring, and cancer treatment are some of the key applications of liquid biopsy.
Get a Sample PDF at: https://www.researchmoz.us/enquiry.php?type=S&repid=1896551
The global liquid biopsy market can be segmented based on various parameters. Based on end user, the report predicts the reference laboratories segment to emerge dominant in the market by the end of 2026. Furthermore, the segment is likely to expansion at a considerably high pace during the course of the forecast period. Factors such as the availability of trained professionals and the ability to manage various samples simultaneously are likely to create positive growth opportunities for the market.
Regionally, North America held the leading share in the global liquid biopsy market and is forecast to remain dominant through the course of the forecast period. Several prominent companies are domiciled in North America thus catapulting it to the global market's fore. Furthermore, population over here exhibit a high awareness about the latest technologies in healthcare and have higher willingness of spending on advanced treatments. Driven by these factors, the liquid biopsy market will continue expanding at an impressive pace in North America. Furthermore, countries across North America often have favorable reimbursement policies thus creating growth opportunities for the market.
In addition, the report forecasts the liquid biopsy market to witness attractive growth opportunities in Asia Pacific. The improving healthcare infrastructure will support the market's growth across emerging nations in the region. Besides this, Europe is forecast to hold a considerable share in terms of revenue in the global liquid biopsy market. The rising demand from Germany, France, U.K., and other nations will boost the liquid biopsy market in Europe.
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG